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Abstract 
Background: Neuromuscular ultrasound is a noninvasive investigation, which can be easily performed at the bedside 
on the ICU. A reduction in muscle thickness and increase in echo intensity over time have been described in ICU patients, 
but the relation to ICU-acquired weakness (ICU-AW) is unknown. We hypothesized that quantitative assessment of muscle 
and nerve parameters with ultrasound can differentiate between patients with and without ICU-AW. The aim of this cross-
sectional study was to investigate the diagnostic accuracy of neuromuscular ultrasound for diagnosing ICU-AW.
Methods: Newly admitted ICU patients, mechanically ventilated for at least 48 h, were included. As soon as patients 
were awake and attentive, an ultrasound was made of four muscles and two nerves (index test) and ICU-AW was 
evaluated using muscle strength testing (reference standard; ICU-AW defined as mean Medical Research Council 
score <4). Diagnostic accuracy of muscle thickness, echo intensity and homogeneity (echo intensity standard devia-
tion) as well as nerve cross-sectional area, thickness and vascularization were evaluated with the area under the curve 
of the receiver operating characteristic curve (ROC–AUC). We also evaluated diagnostic accuracy of z-scores of muscle 
thickness, echo intensity and echo intensity standard deviation.
Results: Seventy-one patients were evaluated of whom 41 had ICU-AW. Ultrasound was done at a median of 7 days 
after admission in patients without ICU-AW and 9 days in patients with ICU-AW. Diagnostic accuracy of all muscle and 
nerve parameters was low. ROC–AUC ranged from 51.3 to 68.0% for muscle parameters and from 51.0 to 66.7% for 
nerve parameters.
Conclusion: Neuromuscular ultrasound does not discriminate between patients with and without ICU-AW at the 
time the patient awakens and is therefore not able to reliably diagnose ICU-AW in ICU patients relatively early in the 
disease course.
Keywords: ICU-AW, Critical illness myopathy, Critical illness polyneuropathy, Critical illness neuromyopathy, 
Neuromuscular ultrasound, Diagnosis
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Background
Intensive care unit-acquired weakness (ICU-AW) is an 
important cause of morbidity in critically ill patients and 
develops in approximately 50% of patients in the ICU [1, 
2]. Patients with ICU-AW suffer from severe weakness 
affecting all extremities and often fail to wean from the 
ventilator [3]. ICU-AW is caused by muscle dysfunction 
(critical illness myopathy; CIM), nerve dysfunction (criti-
cal illness polyneuropathy; CIP) or a mixed dysfunction 
(critical illness neuromyopathy (CINM) [3].
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ICU-AW is diagnosed by assessment of manual mus-
cle strength, using the Medical Research Council (MRC) 
score [3, 4]. A major limitation of muscle strength test-
ing is that patients need to be awake and cooperative for 
reliable assessment [5]. Since consciousness and coop-
erativeness are often impaired in ICU patients, especially 
in the first days after ICU admission, a diagnosis of ICU-
AW is often delayed [6]. To diagnose ICU-AW at an early 
stage, other diagnostic methods are needed.
Neuromuscular ultrasound (NMUS) is an upcoming 
technique to diagnose muscle disorders [7] and periph-
eral neuropathies [8]. NMUS can detect muscle atrophy 
and changes in muscle architecture. Muscle echo inten-
sity may increase due to an increase in fat and fibrous 
tissue [7]. It can be quantified with computer software 
by calculating the average grayscale level of the muscle, 
which is more accurate and objective than visual evalu-
ation [9]. Nerve cross-sectional area (CSA) and echo 
intensity can also be quantified, as well as increased 
intraneural vascularization [10].
A limited number of muscle ultrasound studies have 
been performed in ICU patients, which were recently 
summarized in two systematic reviews [11, 12]. A 
reduction in muscle thickness [13–20] or CSA [17, 21] 
and increase in echo intensity [16, 17, 22] over time 
are reported. As these studies did not discriminate 
between patients with and patients without ICU-AW, it 
is unknown whether these changes are specific for ICU-
AW and can be used to diagnose ICU-AW, or that these 
changes are found in all ICU patients. Nerve ultrasound 
parameters have never been assessed in ICU patients [11].
The aim of this cross-sectional study was to investi-
gate the diagnostic accuracy of quantitative NMUS for 
diagnosing ICU-AW. We hypothesized that quantitative 
NMUS can discriminate between patients with and with-
out ICU-AW at the time the patient awakens.
Methods
Design and ethical approval
This cross-sectional observational study was performed 
in the mixed medical–surgical ICU of the Academic 
Medical Center, Amsterdam, The Netherlands, and was 
designed in accordance with the STARD criteria [23].
The Institutional Review Board of the Academic 
Medical Center Amsterdam approved the study 
(NL41156.018.12.; 2012_264 #B2013585a), and the 
study was registered in the Netherlands Trial Register 
(NTR4148). Informed consent was obtained from all 
patients prior to inclusion.
Inclusion and exclusion criteria
Consecutive, newly admitted ICU patients, who were 
mechanically ventilated for ≥48  h, were eligible for 
inclusion. Patients with an admission diagnosis of a neu-
romuscular disorder, stroke, cardiac arrest, traumatic 
brain injury, spinal injury, or intracerebral infection or 
space-occupying lesion were excluded. In addition, we 
excluded patients with a poor pre-hospital functional 
status (modified Rankin >3) [24], preceding spinal injury 
and patients in whom no arms or no legs were available 
for muscle strength testing or ultrasound.
Medical Research Council score (the reference standard)
Muscle strength was assessed as soon as patients were 
awake [Richmond Agitation Sedation Scale (RASS) 
between −1 and 1] and cooperative (able to follow 5 ver-
bal commands with facial muscles, as scored by the Score 
of 5 Questions [24]). Assessment was done by trained and 
experienced physiotherapists who were blinded for ultra-
sound results. The MRC score was used for assessment 
of strength in the following six muscle groups bilaterally: 
wrist dorsiflexors, elbow flexors, shoulder abductors, hip 
flexors, knee extensors and ankle dorsiflexors. ICU-AW 
was defined as a mean MRC score <4, in accordance with 
the international consensus statement [3].
Neuromuscular ultrasound measurements (the index test)
On the same day of the muscle strength assessment, 
NMUS testing was done by trained assessors (EW or CV) 
who were blinded for the muscle strength results, using 
an Esaote MyLabTwice ultrasound machine (Esaote, 
Genova, Italy). The biceps brachii (BB) muscle, tibialis 
anterior (TA) muscle and median nerve were measured 
on the left side of the body, and the rectus femoris (RF) 
muscle, flexor carpi radialis muscle (FCR) and peroneal 
nerve on the right side. If ultrasound was not possible 
on the preferred side, for example due to arterial lines or 
dressings, the opposite side was studied.
For muscle assessment, a 4–13 MHz linear array 
transducer was used with constant image acquisition 
settings, including constant focus. Three independent 
transverse images were taken per muscle based on pre-
defined anatomical landmarks (Additional file  1: Figure 
E1; Additional file 1: Table E1). For assessment of muscle 
thickness, depth settings were adapted, if needed.
For quantitative echo intensity analysis, ultrasound 
images were analyzed with an in-house developed soft-
ware routine for MATLAB (R2014b, Mathworks, Natick, 
MA, USA). Briefly, regions of interest (ROIs) for echo 
intensity measurements were drawn within the mus-
cle following the contours of the muscle just below the 
fascia (Additional file  1: Figure E2). The lateral borders 
of the ROI were removed to exclude artifacts on the 
border of each image. The average echo intensity of the 
three images was used for analyses. The standard devia-
tion (SD) of the average gray scale levels, as a measure of 
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homogeneity, was analyzed as described before [16]. A 
more homogenous muscle may be caused by loss of mus-
cle architecture due to muscle breakdown, inflammation 
or fluid retention [16].
Muscle thickness and echo intensity can be age, gender, 
dominance, length and weight dependent [25]. There-
fore, raw ultrasound values were converted to z-scores 
using normal values which were acquired from pub-
lished healthy populations [25, 26] and a new healthy 
population (see Additional file 1: Table E2 for the regres-
sion model formulas and Additional file  1: Table E3 for 
the characteristics of the new healthy control popula-
tion). The z-scores represent the distance between the 
raw ultrasound value and the healthy population mean 
in units of the standard deviation. A z-score is negative 
when the raw score is below the population mean and 
positive when above.
For nerve assessment, a 6–18 MHz linear array trans-
ducer was used with constant image acquisition settings. 
Focus was adjusted according to nerve depth. Intraneu-
ral vascularization was investigated with power Dop-
pler (low pulse repetition frequency 500  Hz, frequency 
11.1  MHz, Doppler gain adjusted until random noise 
was encountered and then lowered until the noise dis-
appeared, low persistence [27]). The median nerve was 
assessed at the wrist and 7 cm proximally and the pero-
neal nerve at the fibular head and at the popliteal fold, 
in a transversal and longitudinal plane. On transverse 
images, the cross-sectional area was measured within 
the hyperechogenic rim. Nerve diameter thickness was 
assessed on longitudinal images.
Clinical data collection
We collected the following clinical characteristics: age, 
sex, body weight and length at ICU admission, hand 
dominance, admission type, admission diagnosis, Acute 
Physiology and Chronic Health Evaluation IV (APACHE 
IV) score, maximal total Sequential Organ Failure 
Assessment (SOFA) score and the presence of sepsis 
(according to the Bone criteria [28]) before inclusion. In 
addition, we collected data on pre-existing polyneuropa-
thy or myopathy, risk factors for polyneuropathy before 
ICU admission (diabetes mellitus, alcohol abuse, chemo-
therapy, kidney failure), days with mechanical ventilation, 
ICU length of stay and ICU mortality.
Sample size estimation
Sample size calculation was based on results of one study, 
in which echo intensity of the TA muscle increased by 
a factor 1.2 between 0 and 14 days after ICU admission 
[16]. We used the standardized echo intensity of the TA 
for males (33.9 SD 9.3) [25] and multiplied this value by 
factor 1.2, giving 40.8, again assuming a SD of 9.3. Thirty 
patients per group were required to detect a difference 
of 6.9 (40.8–33.9) with 80% power and a two-sided alpha 
level of 0.05. Incidence of ICU-AW in patients mechani-
cally ventilated for >48 h in our institution is around 50% 
[29, 30]. To account for technically imperfect data, we 
aimed to include at least 70 patients.
Statistical analysis
Normally distributed values are presented as mean with 
SD, non-normally distributed values as median with 
interquartile range (IQR), and proportions with percent-
ages and total numbers. Differences between normally 
distributed continuous variables were assessed using 
Welch’s t test, and between non-normally distributed 
continuous variables using Wilcoxon rank-sum test. 
Pearson’s Chi-square or Fisher exact test was used to 
assess differences between proportions.
As a measure of variability, the median coefficient of 
variation (CV) of three analyses of echo intensity per 
muscle was assessed.
Discriminative power of NMUS was assessed using 
receiver operating characteristic (ROC) curves with 
calculated area under the curve (AUC) with 95% confi-
dence interval (CI). Discriminative power of AUC values 
between 90 and 100% was defined as excellent, between 
80 and 90% as good, between 70 and 80% as fair, between 
60 and 70% as poor and <60% as failed.
Secondly, sensitivity and specificity and positive and 
negative predictive values (PPV, NPV) for muscle thick-
ness and echo intensity were calculated based on a 
z-score cutoff of −2 for thickness parameters and +2 for 
echo intensity. We chose this cutoff point since 95% of 
the z-score values of healthy people lie between −2 and 
+2. Since weakness in ICU-AW is diffuse, we also inves-
tigated a composite outcome of amount of muscles with a 
thickness z-score of −2, or echo intensity of +2.
Analyses were done using R version 3.1.2 and R studio 
with the following packages: plyr, pROC, caret, tableOne, 
ggplot2.
Results
From September 1, 2013 to June 1, 2015, a total of 76 
patients gave informed consent and 71 were available 
for analysis, of whom 41 had ICU-AW. See Fig. 1 for the 
flowchart of screening and inclusion. Patient characteris-
tics are presented in Table 1.
Muscle ultrasound
Thickness and thickness z-scores were lower in BB and 
FCR muscles in ICU-AW patients compared to patients 
without ICU-AW (Table 2; Additional file 1: Figure E3). 
However, discrimination between patients with ICU-AW 
and patients without ICU-AW was poor for BB and FCR 
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and failed for RF and TA thickness and all z-scores of 
thickness (Table 2).
For echo intensity, median CV of three analyses per 
muscle was 1.9–5.1%. Echo intensity was higher in TA 
muscle in ICU-AW patients, but z-scores of echo inten-
sity were not different (Table 2). Discrimination between 
patients with ICU-AW and patients without ICU-AW 
based on echo intensity was poor and failed on z-scores of 
echo intensity.
Sensitivity, specificity, PPV and NPV based on z-score 
cutoff values are presented in Table  3. Specificity was 
high, but sensitivity, PPV and NPV were all low.
Echo intensity SD and z-scores did not differ between 
patients with and without ICU-AW, and discrimination 
failed.
A composite outcome of amount of muscles with 
a thickness z-score of <−2 did not correctly clas-
sify patients [ROC–AUC 54.6% (95% CI 43.7–65.5%)], 
nor did the amount of muscles with an echo intensity 
z-score > 2 [ROC–AUC 56.8% (95% CI 43.4–70.2%)].
Nerve ultrasound
CSA of the median nerve at the wrist was lower in ICU-
AW patients, but showed poor discrimination (Table 4). 
The other nerve CSA and thickness measures were not 
different and discrimination failed. Nerve vasculariza-
tion did not differ between patients with and without 
ICU-AW.
Discussion
This study showed that the diagnostic accuracy of quan-
titative NMUS for diagnosis of ICU-AW is poor when 
assessed at awakening (median 7–9  days after ICU 
admission). A single or composite NMUS measurement 
cannot distinguish between patients with or without 
ICU-AW. For a z-score cutoff of −2 for muscle thickness 
and +2 for muscle echo intensity (corresponding to val-
ues found in 2.3% of healthy individuals), specificity was 
high, but sensitivity and PPV and NPV were low.
Muscle thickness and echo intensity
We found that thickness and z-scores of thickness of BB 
and FCR muscles were significantly lower in ICU-AW 
patients compared to patients without ICU-AW and 
echo intensity of TA was higher. However, there is a huge 
overlap of NMUS values of the two groups, causing low 
diagnostic accuracy. We also found that most z-scores 
were between −2 and +2, which is usually considered the 
normal range (corresponding to values found in 95% of 
healthy people).
More time may be needed for muscle thickness to 
decrease and for echo intensity to increase. Long-term 
studies show that increased time in the ICU is associ-
ated with a substantial reduction in muscle thickness (up 
to 17.7–30.4% at day 10 after ICU admission [17, 21] and 
38.9% after 4  weeks [19]). However, muscle atrophy is 
also seen in healthy volunteers after bed rest and might 
not discriminate between patients with and without ICU-
AW [31]. Moreover, echo intensity may increase more 
slowly. The process of recovery of injured muscle tissue, 
giving an increase in fibrous and/or fat tissue in muscle, 
may not be detectable in the first weeks after initial mus-
cle injury [32]. However, inflammation may be detectable 
earlier. In patients with severe sepsis, semiquantitatively 
graded echo intensity was already significantly higher at 
day 4 after admission compared to controls [22].
To determine diagnostic accuracy, we chose 
the moment of awakening, because it allowed a 
Fig. 1 Flowchart of patient screening and inclusion. ICU intensive 
care unit, MV invasive mechanical ventilation, NMUS neuromuscular 
ultrasound
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cross-sectional design with direct comparison to strength 
measurements. However, a diagnosis of ICU-AW before 
awakening (before muscle strength measurements are 
possible) is more desirable, because an early diagnosis is 
a prerequisite for any future preventive measure or treat-
ment to be implemented. Since we found that diagnos-
tic accuracy of NMUS at awakening was poor, it is less 
likely that differences in thickness and echo intensity 
will be more noticeable before this time point. Besides, 
muscle thickness and echo intensity can be influenced 
by confounding factors, like excessive fluid adminis-
tration, often present in the first days after ICU admis-
sion, impairing the use of NMUS for early diagnosis of 
ICU-AW.
Alternatively, it might be that not the values at one time 
point, but the rate at which muscle size decreases or echo 
intensity increases can discriminate between ICU-AW 
and no ICU-AW. This would require multiple assess-
ments with ultrasound in the first days after ICU admis-
sion to acquire an early diagnosis. Whether the changes 
in muscle thickness or echo intensity in the first days 
after admission would be evident enough to discrimi-
nate between ICU-AW and no ICU-AW is unknown. 
Studies with serial NMUS measurements within the first 
week after admission do not show uniform results: some 
studies showed a decrease in muscle mass at day 7 after 
ICU admission, varying from 12.1% [15] to 6.0–24.9% 
[17], while others did not find changes from baseline in 
the first week after ICU admission [16, 33]. Hence, the 
decrease in muscle thickness might be limited in the 
first week and might become more apparent thereafter. 
The increase in echo intensity is also more obvious after 
7 days on the ICU [16, 17]. Differences between patients 
with and without ICU-AW were not assessed in these 
studies.
Nerve ultrasound in the ICU
To our best knowledge, nerve ultrasound has never been 
investigated before in ICU patients. Diagnostic accuracy 
of nerve thickness or CSA for diagnosing ICU-AW in our 
study was poor. The CSA of the median nerve measured 
at the carpal tunnel at the wrist was smaller in ICU-AW 
Table 1 Patient characteristics
IQR interquartile range, APACHE Acute Physiology and Chronic Health Evaluation, SOFA sequential organ failure assessment, MRC medical research council, NMUS 






Male (%) 22 (73) 25 (61) 0.41
Age (median years [IQR]) 62 [49–69] 60 [51–70] 0.80
Body length (median cm [IQR]) 175 [170–180] 172 [168–183] 0.46
Body weight (median kg [IQR]) 75 [70–81] 75 [65–90] 0.66
History of myopathy (%) 0 (0) 1 (2) 1.00
History of polyneuropathy (%) 0 (0) 0 (0) 1.00
Any polyneuropathy risk factor in history (%) 14 (47) 22 (54) 0.73
 Diabetes mellitus (%) 2 (7) 5 (12) 0.69
 Alcohol abuse (%) 5 (17) 10 (24) 0.56
 Kidney failure (%) 2 (7) 1 (2) 0.57
 Chemotherapy (%) 7 (23) 9 (22) 1.00
Admission reason (%) 0.87
 Medical (%) 12 (40) 18 (44)
 Emergency surgical (%) 9 (30) 10 (24)
 Elective surgical (%) 9 (30) 13 (32)
Dominant hand right (%) 26 (90) 34 (92) 1.00
APACHE IV score (median [IQR]) 58 [50–77] 71 [61–85] <0.01
Maximum total SOFA score before ultrasound (median [IQR]) 8 [8–12] 12 [10–14] <0.01
Sepsis before ultrasound (%) 18 (60) 32 (78) 0.17
Mean MRC (median [IQR]) 4.4 [4.0–4.7] 3.5 [2.8–3.7] NA
Day of MRC (median [IQR]) 7 [4–11] 9 [6–14] 0.02
Day of NMUS (median [IQR]) 7 [5–10] 9 [6–14] 0.02
Length of MV (median days [IQR]) 6 [3–8] 8 [5–17] 0.01
Length of stay on ICU (median days [IQR]) 9 [6–13] 15 [9–23] <0.01
Death in ICU (%) 0 (0) 2 (5) 0.51
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Table 2 Univariate analysis of muscle thickness, echo intensity and echo intensity standard deviation (SD) and z-scores, 
and area under the receiver operating characteristic curve (ROC–AUC)
BB biceps brachii, FCR flexor carpi radialis, RF rectus femoris, TA tibialis anterior
* P < 0.05
No ICU-AW ICU-AW P value ROC–AUC (95% CI)
Thickness
 BB thickness [mean cm (SD)] 2.6 (0.6) 2.2 (0.5) 0.002* 68.0 (55.4–80.7)
 FCR thickness [mean cm (SD)] 1.1 (0.2) 1.0 (0.2) 0.035* 64.5 (50.4–78.7)
 RF thickness [mean cm (SD)] 3.1 (0.9) 2.8 (0.8) 0.258 55.6 (41.8–69.4)
 TA thickness [mean cm (SD)] 2.2 (0.4) 2.1 (0.4) 0.558 54.3 (40.3–68.3)
Z-score thickness
 BB z-score thickness [mean (SD)] 0.1 (0.6) −0.3 (0.5) 0.011* 66.7 (53.7–79.6)
 FCR z-score thickness [mean (SD)] −0.7 (1.2) −1.3 (0.9) 0.033* 65.5 (51.3–79.7)
 RF z-score thickness [mean (SD)] −0.5 (0.7) −0.6 (0.8) 0.656 53.2 (39.4–67.1)
 TA z-score thickness [mean (SD)] −0.4 (0.7) −0.4 (1.0) 0.818 51.3 (37.5–65.1)
Echo intensity
 BB absolute echo intensity [mean gray scale level (SD)] 76.2 (14.1) 79.1 (16.4) 0.434 57.6 (44.0–71.3)
 FCR absolute echo intensity [mean gray scale level (SD)] 62.3 (12.6) 67.7 (13.6) 0.095 63.2 (49.6–76.9)
 RF absolute echo intensity [mean gray scale level (SD)] 77.2 (17.0) 83.9 (14.8) 0.094 60.2 (46.4–74.0)
 TA absolute echo intensity [mean gray scale level (SD)] 88.6 (12.4) 94.6 (12.1) 0.046* 60.8 (47.4–74.1)
Z-score echo intensity
 BB z-score echo intensity [mean (SD)] 0.5 (1.4) 0.7 (1.9) 0.519 56.3 (42.8–69.9)
 FCR z-score echo intensity [mean (SD)] 1.4 (1.6) 1.9 (2.0) 0.207 59.2 (45.2–73.2)
 RF z-score echo intensity [mean (SD)] 1.0 (1.6) 1.6 (1.8) 0.137 58.7 (45.0–72.4)
 TA z-score echo intensity [mean (SD)] 1.0 (1.2) 1.5 (1.4) 0.118 59.4 (45.9–72.9)
Echo intensity SD
 BB echo intensity SD [mean gray scale level(SD)] 29.0 (4.0) 28.5 (4.4) 0.585 53.3 (39.6–67.0)
 FCR echo intensity SD [mean gray scale level(SD)] 21.3 (3.1) 20.8 (3.9) 0.573 56.2 (42.2–70.2)
 RF echo intensity SD [mean gray scale level(SD)] 24.2 (3.3) 23.5 (3.5) 0.398 55.9 (42.0–69.8)
 TA echo intensity SD [mean gray scale level (SD)] 25.8 (3.6) 26.2 (3.9) 0.698 54.4 (40.5–68.3)
Z-score echo intensity SD
 BB z-score echo intensity SD [mean (SD)] 0.3 (1.5) 0.1 (1.5) 0.746 53.3 (39.6–67.0)
 FCR z-score echo intensity SD [mean (SD)] 0.8 (1.4) 0.6 (1.7) 0.716 55.0 (41.0–69.1)
 RF z-score echo intensity SD [mean (SD)] 0.1 (1.6) 0.04 (1.4) 0.890 54.2 (36.9–65.5)
 TA z-score echo intensity SD [mean (SD)] −0.3 (1.1) −0.2 (1.4) 0.777 55.0 (41.1–68.9)
Table 3 Sensitivity, specificity, positive predictive value (PPV) and  negative predictive value (NPV) for  z-score cutoffs 
of −2 for muscle thickness and +2 for echo intensity
Cutoff Sensitivity (%) Specificity (%) PPV (%) NPV (%)
BB thickness Z-score < −2 3 97 50 43
FCR thickness Z-score < −2 27 83 67 48
RF thickness Z-score < −2 3 97 50 43
TA thickness Z-score < −2 8 93 60 43
BB echo intensity Z-score > 2 36 67 58 44
FCR echo intensity Z-score > 2 46 73 68 52
RF echo intensity Z-score > 2 36 67 58 44
TA echo intensity Z-score > 2 38 80 71 49
Page 7 of 9Witteveen et al. Ann. Intensive Care  (2017) 7:40 
patients, and other nerve CSA or thickness parameters 
were not different. This at least indicates that nerve thick-
ness is not increased in ICU-AW when compared to 
patients without ICU-AW, which is in line with an axonal 
neuropathy, since nerve thickness is often increased in 
demyelinating polyneuropathies [8].
It is hypothesized that nerve damage in ICU-AW may 
be caused by increased vascular permeability causing 
endoneurial edema and subsequent hypoxia [34]. To 
compensate, perineural veins may dilate and cause hyper-
emia and hypervascularization, which could be detected 
by NMUS [35]. We found hypervascularization in the 
median nerve in 16 patients and in the peroneal nerve in 
7 patients. However, there were no differences between 
patients with and without ICU-AW.
Strengths and weaknesses
This is the first study investigating the diagnostic accu-
racy of quantitative NMUS for diagnosing ICU-AW, and 
also the first study ever to investigate quantitative nerve 
ultrasound in ICU patients. We used muscle strength 
testing as the reference standard, which is a clinically rel-
evant reference standard and recommended method to 
diagnose ICU-AW [4]. A large number of patients were 
included, and muscles and nerves were investigated with 
ultrasound in a systematic and reproducible way. The use 
of z-scores made the comparisons of measurements more 
reliable because age, gender and muscle side can influ-
ence muscle thickness and echo intensity.
As a first step to determine diagnostic accuracy, we 
investigated NMUS parameters only at the first time 
point on which the reference standard (MRC score) was 
available. A limitation is that we did not perform NMUS 
measurements before or after that time point. We can 
therefore not rule out that a change in thickness or echo 
intensity over time may have a good diagnostic accu-
racy. Additionally, we did not investigate muscle CSA 
as a measure of muscle mass in our study. Furthermore, 
NMUS and strength assessment was performed approxi-
mately 2  days later in ICU-AW patients compared to 
patients without ICU-AW. As there was more time in 
the ICU-AW group for muscle thickness to decrease and 
echo intensity to increase, this may have potentially over-
rated the difference with the group without ICU-AW. 
Given the already low diagnostic accuracy found, this 
only strengthens our conclusions. Additionally, it might 
be that muscles that were not assessed in our study may 
be more sensitive to changes in thickness or echo inten-
sity. Moreover, muscle biopsy or electrophysiological 
recordings were not performed in our study, because 
these are not routinely performed in clinical practice to 
diagnose ICU-AW in our ICU. Therefore, we cannot dis-
criminate between CIP, CIM and CINM in this study.
Although the investigators performing the NMUS were 
blinded for the exact MRC scores, total blinding to mus-
cle strength is not possible, since the presence or absence 
of spontaneous movements of the patient already gives an 
impression of the muscle strength. Additionally, except 
for intra-rater CV of echo intensity measurements, we 
did not assess inter- and intra-rater variability.
A limitation of quantitative NMUS in general is the fact 
that it is complicated to directly compare NMUS results 
between studies, because of differences in image acqui-
sition settings, probe position, ultrasound machines, etc. 
Gray scale levels are specific for the ultrasound machine 
used and cannot be compared to data obtained by other 
ultrasound machines unless calibrated [8]. Calibration 
can be done with a universal phantom.
Table 4 Univariate analysis and area under the receiver operating characteristic curve (ROC–AUC) of nerve parameters
* P < 0.05
a In transversal or longitudinal plane
No ICU-AW ICU-AW P value ROC–AUC (95% CI)
Median nerve
 CSA wrist [mean  mm2 (SD)] 10.7 (3.5) 8.9 (2.1) 0.020* 66.7 (53.6–79.9)
 CSA proximal [mean  mm2 (SD)] 7.3 (1.8) 7.6 (1.7) 0.445 52.5 (38.6–66.4)
 Thickness proximal [mean mm (SD)] 2.4 (0.4) 2.4 (0.4) 0.977 51.0 (37.2–65.2)
 Intraneural vascularization proximal (%)a 6 (20.0) 10 (25.6) 0.793
Peroneal nerve
 CSA fibular head [mean  mm2 (SD)] 10.8 (3.5) 11.7 (5.0) 0.504 53.1 (35.6–70.7)
 CSA knee fold [mean  mm2(SD)] 8.2 (3.3) 8.2 (3.0) 0.999 52.4 (36.9–67.9)
 Thickness knee fold [mean mm (SD)] 2.2 (0.4) 2.3 (0.4) 0.505 54.6 (38.9–70.2)
 Intraneural vascularization proximal (%)a 3 (12.0) 4 (14.3) 1.000
Page 8 of 9Witteveen et al. Ann. Intensive Care  (2017) 7:40 
Conclusion
A single neuromuscular ultrasound at the moment a 
patient awakens does not discriminate between patients 
with and without ICU-AW.
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